These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37348696)

  • 21. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual banned-substance review: Analytical approaches in human sports drug testing 2019/2020.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2021 Jan; 13(1):8-35. PubMed ID: 33185038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidoping Science: Important Lessons From the Medical Sciences.
    Simon P; Neuberger EW; Wang G; Pitsiladis YP
    Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-intentional doping in sports.
    Yonamine M; Garcia PR; de Moraes Moreau RL
    Sports Med; 2004; 34(11):697-704. PubMed ID: 15456345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual banned-substance review - Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2020 Jan; 12(1):7-26. PubMed ID: 31724288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The necessary dialogue between medicine and anti-doping for the integrity of sport and the athlete].
    Faiss R; Salamin O; Astolfi T; Saugy M
    Rev Med Suisse; 2018 Jul; 14(613):1360-1363. PubMed ID: 29998639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging drugs--potential for misuse in sport and doping control detection strategies.
    Thevis M; Schänzer W
    Mini Rev Med Chem; 2007 May; 7(5):531-7. PubMed ID: 17504189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoisomers in sports drug testing: Analytical strategies and applications.
    Thomas A; Thevis M
    J Chromatogr A; 2022 Jul; 1674():463154. PubMed ID: 35613502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma volume expanders: use in medicine and detecting misuse in sports.
    Simoni RE; Scalco FB; de Oliveira ML; Aquino Neto FR
    Bioanalysis; 2011 Jan; 3(2):215-26. PubMed ID: 21250849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.